United-Guardian, Inc.  

(Public, NASDAQ:UG)   Watch this stock  
Find more results for UG
26.82
-0.18 (-0.67%)
After Hours: 26.66 -0.16 (-0.60%)
Jul 25, 4:33PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.65 - 27.20
52 week 24.25 - 35.25
Open 27.00
Vol / Avg. 12,310.00/5,461.00
Mkt cap 123.28M
P/E 21.72
Div/yield 0.48/5.41
EPS 1.23
Shares 4.60M
Beta 0.02
Inst. own 17%
May 7, 2014
Q1 2014 United-Guardian Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 33.74% 38.29%
Operating margin 48.88% 54.30%
EBITD margin - 48.59%
Return on average assets 32.31% 40.01%
Return on average equity 35.88% 43.61%
Employees 33 -
CDP Score - -

Address

230 Marcus Blvd.
HAUPPAUGE, NY 11788
United States - Map
+1-631-2730900 (Phone)
+1-631-2730858 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

United-Guardian, Inc. (United), through its Guardian Laboratories Division (Guardian), manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical and health care products, and specialty industrial products. The Company also conducts research and development, primarily related to the development of cosmetic and personal care products. The Company�s products are into four product categories: pharmaceuticals, personal care products (including cosmetic ingredients), medical products, and industrial products. The Company�s two product lines are the LUBRAJEL line of cosmetic ingredients and medical lubricants, which accounted for approximately 82% of the Company's sales during the year ended December 31, 2011, and its RENACIDIN IRRIGATION (RENACIDIN), a pharmaceutical product that accounted for approximately 13% of its sales during 2011. The Company's products are marketed through collaborative agreements with larger companies.

Officers and directors

Kenneth H. Globus Chairman of the Board, President, General Counsel
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Rubinger Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Director
Age: 71
Bio & Compensation  - Reuters
Peter A. Hiltunen Vice President
Age: 55
Bio & Compensation  - Reuters
Joseph J. Vernice Vice President, Manager - Research and Development, Director - Technical Services
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Roseann LaCorte Controller
Age: 47
Bio & Compensation  - Reuters
Andrew A. Boccone Independent Director
Age: 68
Bio & Compensation  - Reuters
Arthur M. Dresner Independent Director
Age: 72
Bio & Compensation  - Reuters
Lawrence F. Maietta Independent Director
Age: 56
Bio & Compensation  - Reuters
Christopher W. Nolan Sr. Independent Director
Age: 49
Bio & Compensation  - Reuters